Table 8.
Screening path | ||
---|---|---|
Statistic | OC | CTC |
2015 total screenings (000s) | 5501 | 9159 |
Male % | 46.5% | 45.8% |
Female % | 53.5% | 54.2% |
Screenings findings by size of largest polyp | ||
None | 46.3% | 45.9% |
<6 mm (diminutive) | 37.3% | 37.4% |
6–9 mm (small) | 9.1% | 9.5% |
10+ mm (large) | 7.3% | 7.2% |
Any size | 53.7% | 54.1% |
6+ mm | 16.4% | 16.7% |
CTC with follow-up OC % | na | 12.9% |
Average cost per screening | $1036 | $439 |
Average years to rescreen | 8.0 | 4.9 |
na Not applicable
Source: Authors’ simulation. Assumes all Medicare enrollees have perfectly adhered to an OC or CTC screening path since age 50